Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Feb 17;13:1431–1445. doi: 10.2147/OTT.S227831

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Ding et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Regulatory roles of CCAT2 and miR-424 in viability and proliferation of glioma cells. (A) The viability of glioma cells was assessed under the effects of pcDNA3.1-CCAT2 and si-CCAT2-2 or miR-424 mimic and miR-424 inhibitor. *: P<0.05 when compared with the NC group. (B) The pcDNA3.1-CCAT2 and si-CCAT2-2 or miR-424 mimic and miR-424 inhibitor were appraised regarding their influence on the proliferation of glioma cells. *: P<0.05 when compared with the NC group. (C) Contributions of pcDNA3.1-CCAT2 and si-CCAT2-2 or miR-424 mimic and miR-424 inhibitor to the apoptotic rate of glioma cells were compared. *: P<0.05 when compared with the NC group.